drugset / Trial / NCT00204269
Three-Year Trial on a New Testosterone Gel
Phase 3
Unknown
100 enrolled
University Hospital Muenster
Dr. August Wolff GmbH & Co. KG Arzneimittel · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement therapy will be performed with a new Testosterone Gel examined in previous trials as Testosteron Gel Wolff.
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | — | Topical |